Sponsor Pipeline

Elixiron Immunotherapeutics (Hong Kong) Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07223229 Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients Non-segmental Vitiligo Recruiting
Get alerts when Elixiron Immunotherapeutics (Hong Kong) Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free